Medications for Hepatocellular Carcinoma

7 results

  • irinotecan hydrochloride

    (Irinotecan Hydrochloride)
    Qilu Pharmaceutical Co., Ltd.
    Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colorectal carcinoma and for patients whose disease has recurred or progressed after initial fluorouracil-based treatment.

  • irinotecan hydrochloride

    (Irinotecan Hydrochloride)
    Apotex Corp.
    Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colon or rectal carcinoma, and for patients with recurrent or progressed disease following initial fluorouracil-based therapy.

  • irinotecan hydrochloride

    (Irinotecan Hydrochloride)
    Areva Pharmaceuticals,Inc.
    Irinotecan hydrochloride injection is indicated for first-line therapy in combination with 5-fluorouracil and leucovorin for metastatic colon or rectal carcinoma, and for patients whose disease has recurred or progressed after initial fluorouracil-based treatment.

  • kit for the preparation of technetium tc 99m sulfur colloid

    (Technetium Tc 99m Sulfur Colloid Kit)
    Jubilant DraxImage Inc., dba Jubilant Radiopharma
    Technetium Tc 99m Sulfur Colloid Injection is used in adults to localize lymph nodes in breast cancer or malignant melanoma, evaluate peritoneo-venous shunt patency, and for imaging functioning reticuloendothelial cells in the liver, spleen, and bone marrow, as well as assessing esophageal transit and gastroesophageal reflux.

  • lipiodol

    (ethiodized oil)
    Guerbet LLC
    Lipiodol is indicated as a radio-opaque contrast agent for hysterosalpingography in adults, lymphography in both adult and pediatric patients, and selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).

  • sorafenib

    (Sorafenib)
    Teva Pharmaceuticals Inc
    Sorafenib tablets are indicated for the treatment of unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and locally recurrent or metastatic, progressive differentiated thyroid carcinoma that is refractory to radioactive iodine treatment.

  • sorafenib

    (sorafenib)
    Bora Pharmaceutical Laboratories Inc.
    Sorafenib tablets are indicated for treating unresectable hepatocellular carcinoma (HCC) and for patients with locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.